fda removes semaglutide shortage list 2025 from drug february semaglutide no longer available On February 21, 2025, the FDA announced that semaglutide, the active ingredient FDA Update: Current Guidelines for

Wegovy is generally more effective for weight loss because it uses a higher dose of semaglutide, specifically approved for obesity

Once off these drugs, the noise and psychological cravings may reappear, making someone more likely to emotionally eat

Maximizing semaglutide's shelf life requires strict adherence to manufacturer storage guidelines from the moment you receive your medication until administration

Alternating medications could theoretically affect hair loss risk if the cycling produces inconsistent weight loss patterns with periods of rapid loss followed by stabilization followed by rapid loss again

If the allergic reaction was specifically to semaglutide, other GLP-1 receptor agonists may also need to be avoided, though cross-reactivity is not guaranteed and would depend on the nature of the allergic response